Excimer Laser Atherectomy for the Treatment of Infra-inguinal Peripheral Arterial Disease Bryan P Yan MD, Thomas J Kiernan MD, Vishal Gupta MD,

Slides:



Advertisements
Similar presentations
Evolving Strategies in the Treatment of Peripheral Vascular Disease Ravish Sachar MD, FACC Wake Heart and Vascular.
Advertisements

Single Center Experience with Drug Eluting Stents for Infrapopliteal Occlusive Disease in Patients with Critical Limb Ischemia: Mid-term follow up Robert.
Management of distal peripheral vascular disease Cheuk Kwan Yee, Queenie Tuen Mun Hospital.
The Cramping Leg Management of peripheral vascular disease
DEFINITIVE AR - Acute Outcomes -
How to deal with thrombus in ACS "Zap it" - Laser for Thrombus Suneel Talwar Dorset Heart Centre Royal Bournemouth Hospital.
PERIPHERAL VASCULAR DISEASE: A VASCULAR SURGEON’S POINT OF VIEW
When the blood vessels become obstructed, the tissues do not receive the necessary circulation to thrive. Over time, the area may become.
Superficial Femoral Artery Stents - Bare, Covered, or Drug-Coated – “The Data and The HYPE” Dennis F. Bandyk, MD Division of Vascular & Endovascular Surgery.
{ R. Diaz-Garcia MD, J. Bernardo MD Stem Cell Therapy for Patients with Critical Limb Ischemia: A Meta-analysis with Critical Limb Ischemia: A Meta-analysis.
One stage coronary and peripheral intervention Pawel Buszman, MD, American Heart of Poland, Ustron Silesian Medical School, Katowice.
Published in Circulation 2005 Percutaneous Coronary Intervention Versus Conservative Therapy in Nonacute Coronary Artery Disease: A Meta-Analysis Demosthenes.
Chaim Lotan MD, Yaron Almagor MD, Karel Kuiper MD, M.J. Suttorp MD, William Wijns MD The SICTO Study CYPHER TM Sirolimus-eluting stent in Chronic Total.
Klinikum Rosenheim Department of Diagnostic and Interventional Radiology LINC 2014 DEFINITIVE AR Severe Ca++ Arm 30-Day Results Gunnar Tepe, MD On behalf.
Aims To evaluate the technical and clinical outcome of percutaneous transluminal infra-popliteal angioplasties (PTIA) +/- stenting in a subgroup of patients.
Achieving Acute Success and Durable Results with Complete Total Occlusion? Christopher J. Kwolek, MD FACS Harvard Medical School Division of Vascular and.
AICT 2010-Athens Interventional Cardiovascular Therapeutics XI 8-9 OCTOBER 2010 Divani Caravel Hotel, Αthens EARLY CLINICAL OUTCOMES AFTER PROMUS ELEMENT.
LONG-TERM OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE: INITIAL CLINICAL EXPERIENCE. Graidis Ch. 1,
LONG-TERM CLINICAL OUTCOMES AFTER REPEAT DRUG-ELUTING STENT IMPLANTATION FOR IN DRUG-ELUTING STENT RESTENOSIS. C. Graidis, D. Dimitriadis, A. Ntatsios,
Endovascular Treatment of Atherosclerotic Popliteal Artery Lesions – Balloon Angioplasty versus primary Stenting: A prospective, multi-centre, randomised.
The GREAT Trial. The Grampian Region Early Anistreplase Trial Reference Zahringer M, Sapoval M, Pattynama PM, et al. Sirolimus-eluting versus bare-metal.
Material and Methods Patient Population. – From July 2005 through December 2008, 130 patients (130 procedures, 154 limbs, 185 lesions) were treated using.
Translational and Personalized Medicine Initiative: Quality of Care Project Report Peripheral Revascularization Krista Mahoney, Postdoctoral Fellow October.
Date of download: 9/19/2016 Copyright © The American College of Cardiology. All rights reserved. From: Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting.
Prof. Dr. Sigmund Silber, FESC, FACC On behalf of the RESOLUTE
Richard F. Neville, MD Professor, Department of Surgery
Lawrence A. Garcia, MD DISCLOSURES Consulting Fees
Revascularization of the Heart
Diabetic Foot Limb Salvage: A Singapore Experience
Nitinol Stents with Polymer-free Paclitaxel Coating
Norway Grants Erik Staffa, Vladan Bernard, Aleš Bourek
Lutonix® Paclitaxel-Coated Balloon to Treat Obstructive Lesions in the Superficial Femoral and Popliteal Arteries Preliminary Six-Month Results from.
<sup>d</sup>Stands for as long as it is well tolerated.
Journal of Nuclear Cardiology | Official Journal of the American Society of Nuclear Cardiology Artificial Neural Network based model enhances risk.
Michael Siah, M.D. Medstar Georgetown University Hospital
Ben-Dor Itsik, MD Lowell Satler, MD Ron Waksman,MD Augusto Pichard, MD
Stent Graft for the Treatment of ISR:
Use of Laser When the Balloon Cannot Cross
Director: Center for Critical Limb Care Riverside Methodist Hospital
Angiographic Features of Atherosclerotic Superficial Femoral Artery Disease in Diabetics and Non-diabetics Presenting with Claudication Atif Mohammad,
Crossing SFA-Popliteal Artery CTO’s
The Role of Interventional Treatment for The Failing Grafts
Instent Restenosis and Occlusion: Time for Surgical Revision?
Stent Thrombosis Rates in Contemporary Clinical Practice: Insight from a Large Australian Multi-centre Registry BP Yan*, TJ Kiernan, SJ Duffy, DJ Clark,
Risk of post-operative stroke in patients with known extra-cranial carotid artery disease undergoing Non-Cardiac Surgery Heart and Vascular.
Incidence of May-Thurner Syndrome in Patients undergoing Patent Foramen Ovale Closure for Cryptogenic Stroke Thomas J. Kiernan MD, Bryan P Yan MD, Pablo.
Arterial ischemia – acute and chronic.
Advances in Interventional Cardiology
Diabetes mellitus in patients undergoing percutaneous drug-eluting stent implantation: short and long-term results Claudio Moretti, M.D. Division of Cardiology,
Endovascular treatment of internal iliac artery obstructive disease
Unusual case of recurrent renal artery stenosis: lessons to learn
Results ASA score: Epidemiological data: 8 patients: 7 men and 1 woman
REGISTRY ASSESSMENT OF PERIPHERAL INTERVENTIONAL DEVICES (RAPID): Superficial femoral and Popliteal EvidencE Development (SPEED) A NEST Coordinating.
EXCITE ISR Trial design: Participants with femoropopliteal in-stent restenosis were randomized to excimer laser atherectomy + adjunctive angioplasty (n.
RAPID and VISION September 10, 2018 VISION Think Tank Meeting
Regional variation in patient selection and treatment for lower extremity vascular disease in the Vascular Quality Initiative  Peter A. Soden, MD, Sara.
Role of simple and complex hybrid revascularization procedures for symptomatic lower extremity occlusive disease  Hasan H. Dosluoglu, MD, Purandath Lall,
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
Michael C. Stoner, MD, Dorian J. deFreitas, MD, Sachin V
Presentation, treatment, and outcome differences between men and women undergoing revascularization or amputation for lower extremity peripheral arterial.
Division of Endovascular Interventions
Maintenance of Long-Term Clinical Benefit with
Infrainguinal cutting balloon angioplasty in de novo arterial lesions
Atlantic Cardiovascular Patient Outcomes Research Team
Peripheral atherectomy in TransAtlantic InterSociety Consensus type C femoropopliteal lesions for limb salvage  Andrea E. Yancey, MD, David J. Minion,
Lillian Camino, RPVI, RVT; Melissa Easterday BS; Gary Lemmon, MD
Axillary-Bi-Femoral and Axillary-Uni-Femoral Artery Grafts Have Similar Perioperative Outcomes and Patency Thomas W. Cheng1, M.S., Scott Hardouin1, M.D.,
Peripheral Vascular Intervention
Nicolas Mouawad, MD, Chief and Medical Director, Vascular and Endovascular Surgery, McLaren Bay Region A Tale of two lesions.
Presentation transcript:

Excimer Laser Atherectomy for the Treatment of Infra-inguinal Peripheral Arterial Disease Bryan P Yan MD, Thomas J Kiernan MD, Vishal Gupta MD, Jonathan Eisenberg, Robert Schainfeld DO, Michael Jaff DO, Joseph Garasic MD, Kenneth Rosenfield MD, Department of Vascular Medicine & Interventional Cardiology, Massachusetts General Hospital, Boston, MA Background: Excimer laser atherectomy offers a potential therapeutic intervention for infrainguinal arterial disease. Despite promising early results reported in the literature, optimal patient selection for laser atherectomy has yet to be determined. Methods: We analyzed baseline characteristics and outcomes of consecutive patients (Dec 04 - Nov 07) undergoing laser atherectomy. Changes in ankle brachial index (ABI), need for repeat intervention and limb salvage were assessed at follow-up. Results: Excimer laser atherectomy was performed in 21 patients (30 lesions) with mean age of 75±7 years. Of these, 71% were male and 34% had diabetes. The indication for intervention was critical limb ischemia in 33% and intermittent claudication in 66%. Of the 30 lesions treated, 19 (63%) were femoropopliteal and 11 (37%) were infrapopliteal. Femoropopliteal Trans-Atlantic Society Classification (TASC) was C in 79%, D in 21%; infrapopliteal TASC lesion distribution was A in 9%, C in 73% and D in 18%. Adjunctive angioplasty and stenting was used in 93% and 33% of cases, respectively. Procedural success (<30% residual stenosis) was 97%. Mean follow-up was 375 days (range 20 to 939 days). At follow-up, clinical improvement was observed in 16 patients (76%) with a mean increase in resting ABI of 0.39±0.21. There was one cardiac death, one patient (3.3%) required amputation and 5 lesions (17%) underwent repeat target lesion revascularization. The average time to re-intervention was 80 days. Limb salvage rate in patients with critical limb ischemia was 83% at mean follow-up of 390 days. Table 1. Baseline Characteristics Figure 1. Mechanism of Excimer Laser Photo-ablation ‘Photoablation’ is the use of ultraviolet laser light (308nm) to dissolve and remove matter (1) Light pulse targets tissue for 125 billionths of a second (50 microns penetration depth) dissolve molecular bond (2) Energy absorption creates molecular vibration through heating of intracellular water - water vaporizes, ruptures cells & produce a vapor bubble (3) Expansion and collapse of vapor bubble breaks down tissue and clears byproducts away from tip Variables N = 21 Age (yrs) Men Smokers (current) Diabetes Mellitus Coronary Artery Disease Hypertension Hyperlipidemia Renal Failure Indication Claudication Critical Limb Ischemia 75±7 71% 13% 34% 53% 80% 87% 17% 57% 37% Table 2. Procedural Characteristics Variables N = 30 Vessel Treated Femoro-popliteal Infra-popliteal TASC, femoro-politeal / infra-popliteal A B C D Adjunctive balloon angioplasty Adjunctive stenting Procedural success (<30% residual stenosis) 19 (63%) 11 (37%) 0% / 9% 0 / 0 79% / 73% 21% / 18% 93% 33% 97% Table 3. Clinical Outcomes CONCLUSIONS: In an academic endovascular practice, adjunctive use of excimer laser atherectomy for infrainguinal atherosclerotic disease is associated with high initial technical success and high limb salvage rates Procedural Distal Embolization Mean 375 days Follow-up Death Clinical Improvement Mean increase in Ankle-Brachial Index Target Lesion Revascularization Amputation Limb Salvage for Critical Limb Ischemia 6.7% 3.3% 76% 0.39±0.21 17% 83%